Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1353 of 5804
-
Digital Check-In could ease cancer treatment side effects
Symptom relief Recruiting nowThe PI and the research team developed the New York University (NYU) Electronic Patient Visit Assessment (ePVA) for head and neck cancer (HNC) as a patient-reported outcome measure (PRO) for the early detection of uncontrolled symptoms. The ePVA is digital patient-reported sympto…
Phase: NA • Sponsor: The University of Texas Health Science Center, Houston • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
Can this pill tame the nausea from popular Weight-Loss shots?
Symptom relief CompletedAdult participants with BMI between 22 - 35 kg/m2 will be enrolled and randomized to receive either NG101 (20 mg twice daily \[BID\]) or placebo for 5 days beginning on Day 1. On Day 2, all participants will receive a single subcutaneous injection of a Glucagon-like Peptide-1 (GL…
Phase: PHASE2 • Sponsor: Neurogastrx, Inc. • Aim: Symptom relief
Last updated Jun 26, 2026 13:29 UTC
-
New antibody tackles stubborn biofilms in cystic fibrosis lungs
Disease control CompletedCMTX-101 is a bacterial biofilm disrupting monoclonal antibody being developed as an adjunctive therapy to standard of care antibiotics. The goal of this clinical trial is to assess the safety and tolerability of CMTX-101 in people with cystic fibrosis (pwCF). The main questions…
Phase: PHASE1, PHASE2 • Sponsor: Clarametyx Biosciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New MRI tracks Cancer's energy use to spot tumors
Diagnosis Recruiting nowMany human diseases are characterized by their ability to alter existing metabolic pathways and interrupt cellular processes. Cancer exploits the Warburg effect and utilizes greater glucose than normal cells and within this process uses anaerobic respiration, leading to increased…
Phase: PHASE1, PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Diagnosis
Last updated Jun 27, 2026 07:51 UTC
-
RSV vaccine study tests multidose vial safety
⭐️ VACCINE ⭐️ CompletedRespiratory Syncytial Virus (RSV) is a common type of virus (germ) that can cause severe illness, where medical help is needed. RSV can lead to airway diseases in all ages. Vaccines help your body make antibodies. These antibodies help fight against diseases. This is called an im…
Phase: PHASE3 • Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 07:51 UTC
-
New study aims to stop suicides by connecting jail and hospital data
Knowledge-focused Recruiting nowThis study aims to harmonize jail release record data with electronic health record data in order to connect patients to an evidence-based suicide prevention and clinical care pathway upon jail release.
Phase: NA • Sponsor: Henry Ford Health System • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Hope for rare kidney disease: drug trial targets protein leak
Disease control Recruiting nowThe purpose of this research is to learn if Obinutuzumab is effective and safe in treating patients with fibrillary glomerulonephritis (FGN).
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Experimental pill aims to shield the liver during cancer treatment
Disease control Recruiting nowThe goal of this clinical trial is to assess the efficacy of FB-1603 on improving liver function impairment in hepatocellular carcinoma patients receiving transarterial chemoembolization. The main question it aims to answer is: Changes in the level of liver function parameters, …
Phase: PHASE1, PHASE2 • Sponsor: Febico Biomedical Corp. • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Brain scans could reveal hidden stroke risk in artery disease patients
Knowledge-focused Recruiting nowCAPTIVA-MRI is an observational multimodal MR imaging study that is ancillary to the CAPTIVA trial \[a 3-arm, double-blind Phase III trial conducted at approximately 115 StrokeNet sites randomizing patients with stroke attributed to 70-99% intracranial atherosclerotic stenosis (I…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
New skin grafts aim to heal stubborn ulcers faster
Disease control Recruiting nowThe purpose of this study is to compare Pellograft to standard of care modalities in treating diabetic foot ulcers in human subjects, and to compare Sanograft to standard of care in treating venous leg ulcers. The study will demonstrate wound healing outcomes with comparators inc…
Phase: NA • Sponsor: Surgenex • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
AI model aims to end guesswork in colorectal cancer chemo
Knowledge-focused Recruiting nowColorectal cancer (CRC) remains one of the leading causes of cancer-related mortality worldwide. Although adjuvant chemotherapy improves survival after curative resection, its efficacy varies widely among patients. The absence of reliable predictive biomarkers often leads to over…
Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
New catheter lock may cut blockages in kids on long-term nutrition
Disease control Recruiting nowA multi-site, randomized, 2-arm open-label trial to determine if 4% Tetrasodium (EDTA) catheter lock solution is more effective than heparin lock (standard of care) in preventing central venous catheter occlusions in children with intestinal failure (IF) on total parenteral nutri…
Phase: NA • Sponsor: SterileCare Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New drug HRS-7535 aims to protect kidneys in diabetes patients
Disease control CompletedThe study is a 16-week multicenter, randomized, double-blind, placebo-controlled, parallel-designed Phase II clinical study. The aim of this trial is to evaluate the efficacy and safety of HRS-7535 in subjects with diabetic kidney disease in type 2 diabetes.
Phase: PHASE2 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Heart drug may stop common complication after esophageal cancer surgery
Prevention Recruiting nowThis phase II trial studies how well amiodarone works in the prevention of atrial fibrillation (AF) after a minimally invasive esophagectomy (MIE) in patients with esophageal cancer. Atrial fibrillation (AF) is an irregular heart rhythm, usually associated with a rapid rate, that…
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Prevention
Last updated Jun 27, 2026 12:36 UTC
-
Radiation boost may extend life for liver cancer patients after immunotherapy stalls
Disease control Recruiting nowHCC is a huge healthcare burden in Hong Kong and is one of the top 5 cancers in terms of incidence and mortality in Hong Kong. Patients with advanced HCC are treated with immunotherapy-based as first-line treatment as a standard of care. At the moment, there is limited evidence t…
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New imaging agent could sharpen brain tumor detection
Diagnosis Recruiting nowThis is a single center study investigating the use of Fluoroethyltyrosine (FET) in the detection of brain tumors. FET accumulates in malignant cells within intracranial neoplasms and can be used to detect recurrent disease and characterize grade of glial neoplasms.
Sponsor: Thomas Hope • Aim: Diagnosis
Last updated Jun 27, 2026 12:03 UTC
-
Powder could replace needles and clips for stomach bleeds
Disease control Recruiting nowA prospective, multi-center, noninferiority randomized controlled trial designed to compare the efficacy of UI-EWD (Nexpowder™) hemostatic powder versus conventional endoscopic hemostatic therapy in patients presenting with acute overt gastrointestinal bleeding which is found at …
Phase: NA • Sponsor: Medtronic - MITG • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Immune cell therapy takes on kidney disease
Disease control Recruiting nowA single arm, open-label pilot study is designed to determine the safety and effectiveness of anti-CD19 CAR NK cell injection (KN5501) in patients with immune nephropathy. 36 patients are planned to be enrolled in the dose-escalation trial. The primary endpoints are DLT and TEAEs…
Phase: EARLY_PHASE1 • Sponsor: Changhai Hospital • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Blood test may predict chemo success in advanced colon cancer
Knowledge-focused Recruiting nowThe EpiCORE study aims to identify cfDNA-based epigenetic markers predictive of response to first-line chemotherapy (FOLFOX or FOLFIRI) in metastatic colorectal cancer (mCRC). By integrating 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) profiling, this study seeks to…
Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
New blood test spots silent spread of bile duct cancer before surgery
Knowledge-focused CompletedOccult metastasis at the time of surgery is a major driver of poor outcomes in intrahepatic cholangiocarcinoma (ICC), yet reliable preoperative biomarkers to identify such patients are lacking. The EXOMIC study aims to develop and validate a circulating exosomal microRNA (exo-miR…
Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC